A

Avisa Diagnostics Inc
CNSX:AVBT

Watchlist Manager
Avisa Diagnostics Inc
CNSX:AVBT
Watchlist
Price: 0.045 CAD Market Closed
Market Cap: CA$2.7m

Avisa Diagnostics Inc
Investor Relations

Avisa Diagnostics, Inc. is a clinical stage medical device company. The company is headquartered in Santa Fe, New Mexico. The company went IPO on 2010-02-16. The firm develops the Avisa BreathTest, a drug/device biomarker technology platform that enables the detection of bacterial pathogens, detecting and monitoring bacterial load after the patient inhales or ingests its drug substrates. The firm conducts trials in cystic fibrosis, tuberculosis and community-acquired pneumonia. Its drug/device is in late-stage clinical development, which measures the lung and live organisms. The firm develops, AVISARTM instrument, which contains a touchscreen operator interface, nebulizer controller, breath sampling pneumatics and a laser spectrometer. Its Avisa BreathTest kit contains lyophilized AV-U13 drug, pre-filled syringe of sterile water, breath collection and biologic filter components and aerogen solo mesh nebulizer.

Show more
Loading
AVBT
S&P TSX Composite Index (Canada)
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. David S. Joseph
Pres, CEO & Chairman
No Bio Available
Mr. Matt Culler
Advisor
No Bio Available
Philip Ross
Pres
No Bio Available
Dr. Graham Timmins Ph.D.
Chief Science Advisor & Member of Science Advisory Board
No Bio Available
Dr. Richard K. Murray M.D.
Chief Medical Officer
No Bio Available

Contacts

Address
NEW MEXICO
Santa Fe
1660A Old Pecos Trail
Contacts
+15058201400.0
www.avisadx.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett